Search criteria | ||||
Cost per Episode of Care With Collagenase Clostridium histolyticum Versus Fasciectomy for Dupuytren Contracture: A Real-World Claims Database Analysis | ||||
Camper S, Divino V, Hurley D, DeKoven M | ||||
Endo; IQVIA | ||||
Journal of Hand Surgery Global Online. 2019; 1(2):57-64. |
||||
, Article | ||||
, USA | ||||
Abstract: https://doi.org/10.1016/j.jhsg.2018.12.005 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Cost analysis, Retrospective database analysis | |
Return to Function in Adults with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum Versus Fasciectomy | ||||
Divino V, DeKoven M, Hurley D | ||||
IQVIA; Endo | ||||
Conference. 74TH ANNUAL MEETING OF THE ASSH. Las Vegas, Nevada, USA, 5-7 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Retrospective database analysis | |
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE | ||||
Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi | ||||
Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands | ||||
Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019 |
||||
, Poster | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Musculoskeletal disease | 2019 | English | , Survey research | |
Budget impact analysis of tofacitinib in adult rheumatoid arthritis patients in Iraq | ||||
N. AlAni1, N. Sunna2, A. Ghorab3, A. AlJabban4, N. Awad5, O. Mohamed5 | ||||
Baghdad College of Medicine, Baghdad, Iraq, Pfizer, Amman, Jordan, ; Pfizer, Dubai, United Arab Emirates; Pfizer, Baghdad, NJ, USA; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.705 |
||||
, Article | ||||
, Iraq | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30897-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Budget impact, Prospective study | |
Budget Impact Analysis Of Golimumab In Adult Rheumatoid Arthritis Patients In Kingdom Of Saudi Arabia | ||||
A. Al Jedai1, H. AL-Mudaiheem1, P. Pathak2, N. Awad2, O. Mohamed2, N. Alghanim1, W. Hussain1, A. Qamar1, T. Alama1 | ||||
Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; IQVIA, Dubai, United Arab Emirates; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia; Ministry of Health, Riyadh, Saudi Arabia | ||||
DOI: https://doi.org/10.1016/j.jval.2019.04.087 |
||||
, Article | ||||
, Saudi Arabia | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)30279-7/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2019 | English | , Budget impact, Predictive analytics | |
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use | ||||
Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M | ||||
IQVIA | ||||
Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372 |
||||
, Article | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology, Risk Management & REMS | 2019 | English | , Survey research | |
Do characteristics of patients influencing the choice of pain treatment by GPs differ in osteoarthritis and cancer? – An Italian real world data study | ||||
Heiman F1, Pegoraro V1, Moretti R1 | ||||
1 QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Oncology, Pain | 2017 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective database analysis | |
Severe depression as a risk factor for osteoporosis: a real world data study conducted in Italy | ||||
Heiman F1, Moretti R1, Pegoraro V1 | ||||
QuintilesIMS, Milan, Italy | ||||
ISPOR 20th Annual European Congress, 4-8 November 2017, Glasgow, Scotland |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Musculoskeletal disease | 2017 | English | , Database Study, Epidemiological study, Real World Data, Real World Evidence, Retrospective cohort analysis, Retrospective database analysis | |
Depression risk in patients with late-onset rheumatoid arthritis in Germany | ||||
Drosselmeyer J, Jacob L, Rapp M, Kostev K | ||||
Qual Life Res. 2017 Feb;26(2):437-443 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Musculoskeletal disease | 2017 | English | ||
Creating a Rare Disease Cohort Using Ambulatory Electronic Medical Record (AEMR) Data: Duchenne Muscular Dystrophy (DMD) | ||||
Anderson A1, Casso D1, Susan A. Oliveria SA 1, Douglas Kou T 2 | ||||
1 QuintilesIMS ,2 BMS | ||||
33rd International Conference on Pharmacoepidemiology & Thereputic Risk Management; August, 28, 2017; Montreal, Canada |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Musculoskeletal disease, Patient Registries & Real-World Study Methods, Rare Diseases | 2017 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Gender- and age-related treatment compliance in patients with osteoporosis in Germany | ||||
Hadji P, Jacob L. Kostev K | ||||
Patient Prefer Adherence. 2016 Nov 23;10:2379-2385 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2016 | English | ||
The use of proton pump inhibitors is positively associated with osteoporosis in postmenopausal women in Germany | ||||
Jacob L, Hadji P, Kostev K | ||||
Climacteric. 2016 Oct;19(5):478-81 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Womens Health | 2016 | English | ||
Prevalence with and type of antidepressant therapy used by German general practitioners to treat female patients with osteoporosis | ||||
Drosselmeyer J, Rapp M, Kostev K | ||||
Int J Clin Pharmacol Ther. 2016 Oct;54(10):743-9 |
||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Musculoskeletal disease, Womens Health | 2016 | English | , Epidemiological study | |
Depression risk in female patients with osteoporosis in primary care practices in Germany | ||||
Drosselmeyer J, Hadji P, Rapp M, Kostev K | ||||
Osteoporos Int. 2016 Sep;27(9):2739-44 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Mental health, Musculoskeletal disease | 2016 | English | ||
Second-line therapy with biological drugs in rheumatoid arthritis patients in German rheumatologist practices: a retrospective database analysis | ||||
Gossen N, Jacob L, Kostev K | ||||
Rheumatol Int. 2016 Aug;36(8):1113-8 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2016 | English | , Retrospective database analysis | |
A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom | ||||
Raluy-Callado M, Gabriel S, Dinet J, Wang M & Wasiak R | ||||
Retrospective Observational Studies, Evidera Retrospective Observational Studies, Evidera | ||||
Neuropsychiatr Dis Treat. 2015 Mar 9;11:647-55. doi: 10.2147/NDT.S78618. eCollection 2015 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25834443 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Pain | 2015 | English | , Retrospective database analysis | |
Parents’ expressed emotion and mood, rather than their physical disability are associated with adolescent adjustment: A longitudinal study of families with a parent with multiple sclerosis | ||||
A Bogosian 1, J Hadwin 2, M Hankins 3, R Moss-Morris 4 | ||||
1 Psychology Department, City University, UK 2 Psychology Department, Southampton University, UK 3 Real-World Evidence Solutions, IMS Health, UK 4 Institute of Psychiatry, Psychology and Neuroscience, King’s College London, | ||||
Clin Rehabil. 2015 Apr 14 |
||||
, Article | ||||
, England, Europe | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25872520 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Neurological disorders, Oncology | 2015 | English | , Longitudinal study | |
Patterns of systemic lupus erythematosus expression in Europe | ||||
Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12 | ||||
1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France | ||||
Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629 |
||||
, Article, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders | 2014 | English | , Epidemiological study, Observational study, Prospective study | |
Comorbidities in rotator cuff disease: a case-control study | ||||
Titchener AG, White JJ, Hinchliffe SR, Tambe AA, Hubbard RB & Clark D | ||||
Royal Derby Hospital Department of Trauma and Orthopaedics | ||||
J Shoulder Elbow Surg. 2014 Sep;23(9):1282-8. doi: 10.1016/j.jse.2013.12.019. Epub 2014 Mar 4 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24618192 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2014 | English | , Retrospective database analysis | |
The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium. | ||||
Body JJ1, Chevalier P2, Gunther O3, Hechmati G4, Lamotte M2 | ||||
1 CHU Brugmann, Université Libre de Bruxelles, Brussels, Belgium 2 IMS Health, Vilvoorde, Belgium 3 Centre for Observational Research, Amgen Ltd, Uxbridge, UK 4 Health Economics, Amgen (Europe) GmbH, Zug, Switzerland | ||||
J Med Econ., 2013, 16(4): 539-46 |
||||
, Article, Manuscript in preparation | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Oncology | 2013 | English | , Burden of illness | |
The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective | ||||
Lloyd A1, Boomershine CS2, Choy E3, Chandran A4, Zlateva G4 | ||||
1 IMS Health, London, UK 2 Vanderbilt University, Nashville, TN, USA 3 Cardiff University School of Medicine, Cardiff, UK 4 Pfizer Inc., New York, NY, USA | ||||
Journal of Medical Economics 15(3):481-492 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=j+med+econ%5BJour%5D+AND+Lloyd+A%5Bfirst+author%5D+AND+pregabalin&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2012 | English | , Cost effectiveness | |
"GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates " | ||||
Hadji P1, Claus V2, Steinle T3, Intorcia M4, Kostev K3, Ziller V1 | ||||
1 Klinik für Gynäkologie, Gynäkologische Endokrinologie und Onkologie, Philipps-University, Marburg, Germany; 2 IMS Health GmbH & Co. OHG, Munich and Frankfurt, Germany; 3 Health Economics, Amgen GmbH, Munich, Germany; 4 iHE, Amgen (Europe) GmbH, Zug, Switzerland | ||||
Osteoporosis International DOI 10.1007/s00198-011-1535-z |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Musculoskeletal disease | 2011 | English | , Retrospective cohort analysis | |
Description of oral glucocorticoid prescriptions in general population | ||||
Fardet L1, Petersen I, Nazareth I. | ||||
1Service de médecine interne, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France | ||||
Rev Med Interne. 2011 Oct;32(10):594-9. doi: 10.1016/j.revmed.2011.02.022. Epub 2011 Mar 21. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21420765 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2011 | English | , Retrospective database analysis | |
Prevalence of long-term oral glucocorticoid prescriptions in UK over the past 20 years. | ||||
Fardet L, Petersen I, Nazareth I. | ||||
UCL MRC General Practice Research Framework | ||||
Rheumatology (Oxford). 2011 Nov;50(11):1982-90. doi: 10.1093/rheumatology/ker017. Epub 2011 Mar 10. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21393338 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology | 2011 | English | , Epidemiological study, Retrospective database analysis | |
Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands | ||||
Netelenbos JC1, Geusens PP, Ypma G, Buijs SJ. | ||||
1Department of Internal Medicine, VU University Medical Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands | ||||
Osteoporos Int. 2011 May;22(5):1537-46. |
||||
, Article | ||||
, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Musculoskeletal disease | 2011 | English | , Retrospective database analysis | |
The cost-effectiveness of Pregabalin (lyrica®) in the treatment of severe fibromyalgia in the United States. | ||||
Lloyd A1, Castelnuovo E1, Boomershine CS2, Choy E3, Chandran A4, Zlateva G4 | ||||
1IMS Health, London, UK, 2Division of Rheumatology and Immunology, Vanderbilt University, Nashville, TN, USA, 3King's Musculoskeletal Clinical Trials Unit, King's College, London, UK, 4Pfizer Inc., New York, NY, USA | ||||
ISPOR 15th Annual International Meeting May 15-19, 2010 Hilton Atlanta, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Cost effectiveness | |
Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective. | ||||
Choy E1, Richards S2, Bowrin K3, Watson P3, Lloyd A3, Sadosky A4, Zlateva G4. | ||||
1King’s Musculoskeletal Clinical Trials Unit, Academic Department of Rheumatology, King’s College, London,UK 2Poole Hospital NHS Foundation Trust, Poole, UK 3 IMS Health, Health Economics and Outcomes Research, London, UK 4 Pfizer Global Pharmaceuticals, New York, NY | ||||
Curr Med Res Opin. 2010; 26(4): 965-975 |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Lloyd+A%5Bauthor%5D+AND+pregabalin&TransSchema=title | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Cost effectiveness | |
Methods for interpreting tumor necrosis factor (TNF) blocker dosing and treatment patterns from pharmacy and professional claims. | ||||
Makin C1, Schabert V2, Harrison DJ3, Goodman S4 | ||||
1IMS Health, Plymouth Meeting, PA, USA, 2IMS Health, Santa Barbara, CA, USA, 3Amgen, Newbury Park, CA, USA, 4IMS Health, Watertown, MA, USA | ||||
ISPOR 15th Annual International Meeting, May 15-19, 2010, Atlanta, GA, USA |
||||
, Poster | ||||
, USA | ||||
Abstract: http://www.ispor.org/meetings/atlanta0510/Posters2.aspx | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Methodology | |
GRAND: The German retrospective cohort analysis on non-adherence in osteoporosis: Analysis of repsistence with intravenous bisphosphonates in women | ||||
Hadji P1, Claus V2, Kostev K3 Intorcia M4, Steinle T5 | ||||
1 Klinik fur Gynakologie, Gynakologisch, Philipps-University, Marburg, Germany 2 Health Economics & Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany 4 Centre of Excellence Patient Data, IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany 5 Health Economics, Amgen GmbH, Munich, Germany | ||||
IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010 |
||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Musculoskeletal disease | 2010 | English | , Retrospective cohort analysis | |
Non-adherence in women with osteoporosis treated with oral bisphosphonates: German retrospective cohort analysis on non-adherence (GRAND) | ||||
Hadji P1, Claus V2, Steinle T3, Kostev K4, Intorcia M5 | ||||
1 Philipps-University of Marburg, Marburg, Germany, 2 IMS Health GmbH & Co. OHG, Munich, Germany, 3 Amgen GmbH, Munich, Germany, 4 IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany, 5 Amgen Europe GmbH, Zug, Switzerland | ||||
IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010 |
||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Musculoskeletal disease | 2010 | English | , Retrospective cohort analysis | |
Non-compliance and associated risk of fracture in osteoporosis is patients treated with oral bisphosphonates: German retrospective cohort analysis on non-adherence (grand) | ||||
Claus V1, Steinle T2, Kostev K3, Intorcia M4 | ||||
1 Health Economics & Outcomes Research, IMS Health GmbH & Co. OHG, Munich, Germany 2 Health Economics, Amgen GmbH, Munich, Germany 3 Centre of Excellence Patient Data, IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany, 4 iHE, Amgen (Europe) GmbH, Zug, Switzerland | ||||
IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis Florence, Italy, May 5-8, 2010 |
||||
, Abstract, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Musculoskeletal disease | 2010 | English | , Retrospective cohort analysis | |
Pregabalin is cost effective for FM: US and UK comparison | ||||
Chandran AB1, Lui J1, Choy E2, Boomershine C2, Castelnuovo E3, Lloyd A3, Zlateva G1 | ||||
1 Pfizer Inc, US 2 Vanderbilt University, US 3 IMS Health, London, UK | ||||
American Academy of Pain Management, 21st Annual Clinical Meeting, September 21-24, 2010, Caesars Palace, Las Vegas, Nevada, US |
||||
, Poster | ||||
, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Cost effectiveness | |
Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France. | ||||
Lamotte M, Maugars Y, Le Lay K, Taïeb C | ||||
Clin Exp Rheumatol, 2010; 28 (Suppl. 63): S64-S70 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Economic evaluation | |
Cost-effectiveness of tapentadol prolonged-release (PR) compared to oxycodone and morphine in patients with chronic moderate to severe non-cancer pain in Sweden | ||||
Hertel N1, Ikenberg R1, Fricke FU12, Liedgens H3 | ||||
1IMS Health, Nuremberg, Germany 2Georg Simon Ohm University of Applied Sciences, Nuremberg, Germany 3Gruenenthal GmbH, Aachen, Germany | ||||
ISPOR November 6-9, 2010 Prague, Czech Republic |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Musculoskeletal disease | 2010 | English | , Cost benefit | |
The cost utility of autologous chondrocytes implantation using ChondroCelect in symptomatic knee cartilage lesions in Belgium. | ||||
Gerlier L1, Lamotte M1, Wille M2, Kreuz PC3, Vanlauwe J4, Dubois D5, Meurgey FM6 | ||||
1 IMS Health Consulting, Vilvoorde, Belgium 2 TiGenix NV, Leuven, Belgium 3 University Medical Center Rostock, Rostock, Germany 4 University Hospital Pellenberg, Leuven, Belgium 5 Patient Value Solutions, Huldenberg, Belgium 6 Oukelos SPRL, Brussels, Belgium | ||||
, Article | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | ||
Longitudinal assessment of gout in a large sample of italian patients:prevalence and disease management in GPs offices | ||||
Heiman F1, Katz P1 | ||||
1 BKL Consulting SRL, Milan, Italy | ||||
ISPOR Annual European Congress - Prague |
||||
, Poster | ||||
, Italy | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Retrospective database analysis | |
Cost-utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage defects (Belgium). | ||||
Gerlier L1, Lamotte M1, Wille M2, Dubois D3, Meurgey F4 | ||||
1 IMS Health, Brussels, Belgium 2 TiGenix, Leuven, Belgium 3 Patient Value Solutions, Huldenberg, Belgium 4 Oukelos, Brussels, Belgium | ||||
ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France |
||||
, Poster | ||||
, Belgium | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2009 | English | , Cost utility | |
Patterns of Use, Outcomes, and Costs of Selected Viscosupplementation Agents in Health Plan Administrative Data. | ||||
Yeaw J1, DeKoven MP2, Mozaffari E, Tierce J2 | ||||
1 IMS Health, Watertown, MA, US 2 IMS Health, Falls Church, VA, US | ||||
J Manag Care Pharm;2008;14(2):239 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost analysis | |
Cost-effectiveness of transdermal opioids regarding opioid-related fractures in Germany - a model approach | ||||
Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3 | ||||
1 IMS Health, Nuremberg, Germany, 2 EAH Consulting, Juelich, Northrhine Westf, Germany 3 Grünenthal GmbH, Aachen, Germany | ||||
ISPOR 13th Annual International Congress, May 3-7, 2008 ,Toronto, Canada |
||||
, Abstract, Oral presentation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost effectiveness | |
Impact of skeletal complications on patients' quality of life, mobility, and functional independence | ||||
Costa L1, Badia X, Chow E3, Lipton A4, Wardley A5 | ||||
1 Instituto de Medicina Molecular-Lisboa, Hospital de Santa Maria, Lisbon, Portugal 2 Health Economics and Outcomes Research, Barcelona, Spain 3 Radiation Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada 4 Hershey Medical Center, Pennsylvania State University, Hershey, USA 5 Cancer Research Department of Medical Oncology, Christie Hospital NHS Foundation Trust, Manchester, UK | ||||
Support Care Cancer 2008;16(8):879-89. Erratum in Supportive Care in Cancer 2008;16(10):1201 |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Quality of life | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Hip Replacement in Canada | ||||
Diamantopoulos A1, Forster F1, Lees M2, McDonald HP3 | ||||
1 IMS Health, London, UK, 2 Bayer HealthCare, Uxbridge, UK, 3 Bayer Inc, Toronto, ON, Canada | ||||
ISPOR 11th Annual European Congress 2008 November 8-11, Athens, Greece Thrombosis and haemostasis, 2010, 104(4): 760-70 |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/20806107 | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost effectiveness | |
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total knee replacement in the UK and Spain. | ||||
Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Gilmour L4, Ashley D4, Piñol C5. | ||||
1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, SC, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK, 5Bayer HealthCare, Barcelona, Spain | ||||
ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, |
||||
, Poster | ||||
, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Cost effectiveness | |
Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. | ||||
Hass B1, Lungershausen J1, Hertel N1, Kotowa W1, Poulsen Nautrup B2, Liedgens H3 | ||||
1 IMS Health, Nuremberg, Germany 2 EAH-Consulting, Juelich, Germany 3 Gruenenthal GmbH, Aachen, Germany | ||||
The European journal of health economics, 21. Dezember 2008 |
||||
, Online article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Musculoskeletal disease | 2008 | English | , Cost effectiveness | |
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. | ||||
Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G | ||||
Curr Med Res Opinion, 2008, 24(9): 2489-2499 |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2008 | English | , Retrospective database analysis | |
Comparison of oral leflunomide and metotrexate SC for the treatment of rheumatoid arthritis: an approach based on the number needed to treat. | ||||
Garcia A , Betegón L ; Echevarria A . | ||||
ISPOR 2007 10th Annual European Congress |
||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2007 | English | ||
Diagnostic management of osteoporosis patient attended in primary health care consults in Spain | ||||
Fuentes M, Ferrer J, Grifols M, Badia X, Guilera M | ||||
Semergen 2007;33(2):45-9 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2007 | Spanish | ||
Characteristics and healthcare costs of patients with fibromyalgia syndrome. | ||||
Berger A1, Dukes E2, Martin S2, Edelsberg J1, Oster G1 | ||||
1 Policy Analysis Inc. (PAI), Brookline, USA 2 Pfizer, New York, USA | ||||
International Journal Clinical Practice, 2007, 61(9): 1498-1508 |
||||
, Article | ||||
, USA | ||||
Abstract: http://fmsglobalnews.wordpress.com/2007/08/26/characteristics-and-healthcare-costs-of-patients-with-fibromyalgia-syndrome-2/ | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2007 | English | , Retrospective database analysis | |
Las preocupaciones en salud de las mujeres con osteoporosis: su satisfacción y adherencia con el tratamiento. [The worries in health of the women with osteoporosis: its satisfaction and adherence with the treatment] | ||||
Ferrer J, Fuentes M, Grifols M, Perulero N, Badia X. | ||||
Rev Esp Enferm Metab Oseas. 2006;15(1):1-7. |
||||
, Manuscript in preparation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | Spanish | , Quality of life | |
The use of the EQ-5D in patients with osteoporosis. | ||||
Cadenas E, Perulero N, Lizán L, Badia X. | ||||
EuroQol Group Scientific Meeting 2006, Barcelona (Spain) 14-15 September |
||||
, Oral presentation | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | English | , Quality of life | |
A clinical tool for the indication of spine X-rays in postmenopausal women with osteoporosis presenting with back pain. | ||||
Roux C, Priol G, Fechtenbaum J, Cortet B, Liu-Leage S, Audran M. | ||||
Ann Rheum Dis. 2006 Jun 22. |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2006 | English | ||